Stock listing
NASDAQ:PANA Panacea Acquisition II Corp Stock
Follow Panacea Acquisition II Corp into a list and get an email when it puts out news.
Last close · NASDAQ:PANA
$10.24 USD
Close on Apr 26, 2023 · No longer trades
- Lowest – highest close
- $9.63 – $11.80 USDSince Aug 24, 2020 · lowest Jan 27, 2022 · highest Jan 5, 2021
Delisted NASDAQ:PANA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PANA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Praveen Tipirneni Other companies: BridgeBio Oncology Therapeutics, Inc. (Non-Executive Director · Since at least Aug 11, 2025); Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Morphic Holding Inc (President and CEO, Director · Jun 26, 2019 – Aug 16, 2024 · Past) | Director · Apr 6, 2021 – Apr 6, 2021 · Past |
| Scott Platshon Other companies: Theravance Biopharma, Inc. (Executive Vice President and Chief Business Officer · Since at least Nov 4, 2026); Zymeworks Inc. (Executive Vice President and Chief Business Officer · Since at least Feb 22, 2024); Nuvation Bio Inc. (Chief Operating Officer · Jun 30, 2020 – Jun 30, 2020 · Past) | Chief Operating Officer · Apr 6, 2021 – Apr 6, 2021 · Past |
| Caroline Stout Other companies: Nuvation Bio Inc. (Chief Investment Officer · Jun 30, 2020 – Jun 30, 2020 · Past) | Chief Investment Officer · Apr 6, 2021 – Apr 6, 2021 · Past |
Log in to ask 6ix AI your own questions about Panacea Acquisition II Corp.